Association between premature mortality and hypopituitarism

Lancet

Volumn 357, Issue 9254, 2001, Pages 425-431

  Tomlinson, J W ^a   Holden, N ^a   Hills, R K ^a   Wheatley, K ^a   Clayton, R N ^b   Bates, A S ^c   Sheppard, M C ^a   Stewart, P M ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^c SOLIHULL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CORTISONE ACETATE; DESMOPRESSIN; FOLLITROPIN; GONADOTROPIN; GROWTH HORMONE; HYDROCORTISONE; PROLACTIN; TESTOSTERONE; THYROTROPIN; THYROXINE; VASOPRESSIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPOPHYSIS TUMOR; HYPOPITUITARISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL;

EID: 0035835469     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)04006-X     Document Type: Article

References (30)

1. Premature mortality due to cardiovascular disease in hypopituitarism
2. The effect of hypopituitarism on life expectancy
3. Increased cerebrovascular mortality in patients with hypopituitarism
4. Life expectancy following surgery for pituitary tumours
5. The natural history of Cushing's syndrome
6. Epidemiology and long-term survival in acromegaly
7. An audit of treatment outcome in acromegaly
8. Mortality and cancer incidence in acromegaly: A retrospective cohort study
9. Mortality and hypopituitarism
10. High incidence of cardiovascular disease and increased prevalence of cardiovascular risk factors in women with hypopituitarism not receiving growth hormone treatment: Preliminary results
11. Incidence of cerebral infarction after radiotherapy for pituitary adenoma
12. The incidence of cerebrovascular accidents in patients with pituitary adenoma
13. The effect of radiation on carotid arteries
14. Stroke after pituitary irradiation
15. Progressive cerebral occlusive disease after radiation therapy
16. Radiotherapy for non-functioning pituitary tumours
17. Daily cortisol production rate in man determined by stable isotope dilution/mass spectometry
18. The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: Evidence for growth hormone modulation of extrarenal 11β-hydroxysteroid dehydrogenase activity
19. Thyroxine prescription in the community: Serum TSH assays as an indicator of under treatment or over treatment
20. Appropriate replacement dose of thyroxine in primary hypothyroidism
21. Low serum thyrotrophin concentrations as a risk factor for atrial fibrillation in older persons
22. Cardiovascular and fracture mortality after treatment for thyrotoxicosis
23. Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults
24. Cardiovascular risk factors in adult patients with growth hormone deficiency
25. Cardiovascular disease and risk factors in adults with hypopituitarism
26. Endothelial dysfunction in hypopituitary adults with growth hormone deficiency
27. Effects of growth hormone replacement on physical performance and body composition in growth hormone deficient adults
28. The favourable effects of growth hormone (GH) substitution on hypercholesterolaemia in GH-deficient adults are not associated with concomitant reduction in adiposity: A 12-month placebo controlled study
29. Growth hormone as a risk factor for premature mortality in healthy subjects from the Paris prospective study
30. The severity of growth hormone deficiency in adults with pituitary disease is related to the degree of hypopituitatism